Amgen Faces More IRS Penalties Over Puerto Rico

Investors tracking Amgen should note the company has acknowledged it may owe $10.7 billion in taxes, interest and penalties.

Updated on Nov. 4, 2026 in Taxes

Bold vector editorial illustration of stacked shipping containers beside glass vials on a dock, in coral, teal, and mustard, illustrating a corporate tax dispute.
The Internal Revenue Service is seeking additional penalties against drugmaker Amgen over Puerto Rico profits, with the company acknowledging a potential $10.7 billion in taxes, interest and penalties. AI Illustration. Upload story photo >

The Internal Revenue Service is seeking additional penalties against drugmaker Amgen in a long-running dispute over profits tied to Puerto Rico operations. Amgen disclosed in its quarterly report that the agency proposed penalties in September for tax years 2016-2018, substantially similar to those demanded for 2013-2015.

Why it matters

The penalties are described as substantially similar to earlier demands, signaling the dispute is extending across additional tax years rather than resolving. Amgen has acknowledged it may owe $10.7 billion in taxes, interest and penalties, a sum large enough to shape the company's financial position.

Amgen has acknowledged it may owe the IRS $10.7 billion in taxes, interest and penalties over the disputed Puerto Rico profits. The separate dollar figure for the newly proposed 2016-2018 penalties was not disclosed.

The players

Internal Revenue Service (IRS)

The federal agency that collects income taxes and enforces tax law, including penalties on corporate filers that owe back taxes.

Amgen

A large biopharmaceutical company whose drug prices and treatments reach millions of American patients and whose tax position affects its financial strength.

The details

Amgen's quarterly report disclosed that the IRS proposed penalties in September covering tax years 2016 through 2018. These proposals mirror the penalties previously demanded for 2013 through 2015, indicating the agency is applying the same position across later years. Because the company has acknowledged a potential $10.7 billion liability, each additional year of disputed profits adds to the overall exposure.

Timeline

  1. September 2026: The IRS proposed penalties against Amgen for tax years 2016-2018.

  2. November 4, 2026: Amgen disclosed the further IRS penalty demands in its quarterly report.

Money Landscape

The proposed 2016-2018 penalties track the earlier 2013-2015 demands, showing the IRS is pursuing the same Puerto Rico profits position across multiple tax periods. For American taxpayers and investors, large multi-year corporate tax disputes like this one can take years to resolve.

This story mainly affects Amgen and its stakeholders, not most households directly. Individuals who own Amgen stock or hold funds that include it may want to watch future company disclosures, and anyone with questions about how corporate tax disputes could affect their holdings should consult a qualified financial professional.

The takeaway

Large corporate tax disputes can span many years and grow as new tax periods are challenged. Investors who follow a company like Amgen can track its quarterly reports for updates on penalties and liabilities.

Further reading

For background on how corporate tax penalties and disputes are handled, explore our Taxes coverage.